These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 621628)

  • 1. Plasma concentrations of thioridazine metabolites and ECG abnormalities.
    Gottschalk LA; Dinovo E; Biener R; Nandi BR
    J Pharm Sci; 1978 Feb; 67(2):155-7. PubMed ID: 621628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of thioridazine and thioridazine metabolites in erythrocytes.
    Svensson C; Nyberg G; Axelsson R; Mårtensson E
    Psychopharmacology (Berl); 1986; 89(3):291-2. PubMed ID: 3088651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
    Shvartsburd A; Nwokeafor V; Smith RC
    Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia.
    Widerlöv E; Häggström JE; Kilts CD; Andersson U; Breese GR; Mailman RB
    Acta Psychiatr Scand; 1982 Oct; 66(4):294-305. PubMed ID: 7148482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.
    Muusze RG; Vanderheeren FA
    Eur J Clin Pharmacol; 1977 Jan; 11(2):141-7. PubMed ID: 837967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.
    Hartigan-Go K; Bateman DN; Nyberg G; Mårtensson E; Thomas SH
    Clin Pharmacol Ther; 1996 Nov; 60(5):543-53. PubMed ID: 8941027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
    Vanderheeren FA; Muusze RG
    Eur J Clin Pharmacol; 1977 Jan; 11(2):135-40. PubMed ID: 320014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients.
    LLerena A; Berecz R; de la Rubia A; Dorado P
    J Psychopharmacol; 2002 Dec; 16(4):361-4. PubMed ID: 12503836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.
    Axelsson R; Mårtensson E; Alling C
    Eur J Clin Pharmacol; 1982 Oct; 23(4):359-63. PubMed ID: 7173306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic changes and serum concentrations in thioridazine-treated patients.
    Axelsson R; Aspenstrom G
    J Clin Psychiatry; 1982 Aug; 43(8):332-5. PubMed ID: 7096274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.
    Hale PW; Poklis A
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):283-9. PubMed ID: 3582423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioridazine-R-sulfoxide and EKG abnormalities.
    Dinovo EC; Gottschalk LA; Biener R; Nandi BR
    Proc West Pharmacol Soc; 1978; 21():311-2. PubMed ID: 693513
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
    Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
    Cohen BM; Lipinski JF; Waternaux C
    Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin.
    Eap CB; Guentert TW; Schãublin-Loidl M; Stabl M; Koeb L; Powell K; Baumann P
    Clin Pharmacol Ther; 1996 Mar; 59(3):322-31. PubMed ID: 8653995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect and plasma level of thioridazine in schizophrenic patients (author's transl)].
    Klein HE; Chandra O; Matussek N
    Pharmakopsychiatr Neuropsychopharmakol; 1975 May; 8(3):122-31. PubMed ID: 1233515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioreceptor assay and high-performance liquid chromatography yield similar results for serum thioridazine and its major metabolites.
    Rao ML; Brown WA; Wagner R
    Ther Drug Monit; 1988; 10(2):184-7. PubMed ID: 3381236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total plasma concentrations, red blood cell concentrations, and radioreceptor assay values compared with unbound plasma concentrations of thioridazine and thioridazine metabolites in psychiatric patients.
    Nyberg G; Svensson C; Olofsson U; Axelsson R; Mårtensson E
    Ther Drug Monit; 1987 Dec; 9(4):426-32. PubMed ID: 3424408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose.
    Heath A; Svensson C; Mårtensson E
    Vet Hum Toxicol; 1985 Apr; 27(2):100-5. PubMed ID: 3992882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.